Q32 Bio Inc.QTTBNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-45.30M
↑ 23% above average
Average (8y)
$-59.03M
Historical baseline
Range
High:$-7.81M
Low:$-119.79M
CAGR
+24.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-45.30M | +5.1% |
| 2023 | $-47.76M | -22.9% |
| 2022 | $-38.85M | +54.9% |
| 2021 | $-86.22M | +28.0% |
| 2020 | $-119.79M | -22.7% |
| 2019 | $-97.60M | -66.4% |
| 2018 | $-58.64M | -100.1% |
| 2017 | $-29.31M | -275.4% |
| 2016 | $-7.81M | - |